Our very own Dr. Aadia Rana, M.D., who is the Principal Investigator for the UAB Study of Treatment And Reproductive Outcomes (STAR) has made national news. Dr. Rana is the Senior Investigator for the National Institutes of Health-funded Long-Acting Therapy to Improve Treatment SUccess in Daily LifE, or LATITUDE, study. This study is for those patients who are struggling to maintain their daily oral regimens. An independent safety monitoring board conducted last month, the monthly cabotegravir and rilpivirine injections were found to be more effective in suppressing HIV compared to daily pills. “This study is critically important because it shows that long-acting injectable HIV medications can provide substantial benefit to a broader population than those covered by the current regulatory approvals,” Rana said. More details about this study and Dr. Rana can be found by clicking HERE
